American Chemical Society--238th National Meeting & Exposition. Novel small molecule therapeutics. 16-20 August 2009, Washington DC, USA.
The Novel Small Molecule Therapeutics session of the American Chemical Society 238th National Meeting and Exposition, held in Washington DC, included topics covering new therapeutic developments in CNS, anti-infective, cardiovascular and anti-inflammatory applications. This conference report highlights selected presentations on PAR2 (protease-activated receptor 2) antagonists, adenosine and P2Y receptor agonists and antagonists, antimicrobials and neuroprotective compounds.
Rotella
David P
DP
Wyeth Research, 865 Ridge Road, Monmouth Junction, Princeton, NJ 08543, USA. rotelld@wyeth.com
D000818:Animals; D002626:Chemistry, Pharmaceutical / Q000639:trends*; D004219:District of Columbia; D055808:Drug Discovery / Q000639:trends; D015507:Drugs, Investigational / Q000378:metabolism / Q000494:pharmacology; D006801:Humans; D018696:Neuroprotective Agents / Q000378:metabolism / Q000494:pharmacology; D004364:Pharmaceutical Preparations / Q000378:metabolism; D044464:Receptor, PAR-2 / Q000037:antagonists & inhibitors / Q000378:metabolism; D012958:Societies, Scientific / Q000639:trends; D014481:United States
D015507:Drugs, Investigational; D018696:Neuroprotective Agents; D004364:Pharmaceutical Preparations; D044464:Receptor, PAR-2